EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in the Application of Cucurbitacin B as an Anticancer Agent

Dongge Yin, Hongyue Chen, Shuting Lin, Yufei Sun, Xiaohong Jing, Rongrong Chang, Yang Feng, Xiaoxv Dong iD, Changhai Qu, Jian Ni, Xingbin Yin iD

International Journal of Molecular Sciences · 19.08.2025 · 26 (16) · 8003

DOI: 10.3390/ijms26168003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.08.2025. Verfasst von Dongge Yin und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China. Hauptthemen laut MEDLINE: Triterpenes, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Young Elite Scientists Sponsorship Program by the Beijing Natural Science Foundation, the National Natural Science Foundation of China, Beijing Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cucurbitacin B (CuB), a tetracyclic triterpenoid compound isolated from Cucurbitaceae plants, exhibits inhibitory effects on various tumor cells (e.g., liver, gastric, and colorectal cancer cells). Since the 1970s–1980s, cucurbitacin tablets containing CuB have been used as an adjuvant therapy for chronic hepatitis and primary liver cancer. CuB exerts anticancer effects through multiple mechanisms: inducing apoptosis, cell cycle arrest (G2/M or S phase), autophagy, and cytoskeleton disruption; inhibiting migration, invasion, and angiogenesis (via VEGF/FAK/MMP-9 and Wnt/β-catenin pathways); regulating metabolic reprogramming and immune responses; inducing pyroptosis, ferroptosis, and epigenetic changes; and reversing tumor drug resistance. These effects are associated with signaling pathways like JAK/STAT, PI3K/Akt/mTOR, and FOXM1-KIF20A. To improve its application potential, strategies such as structural modification (e.g., NO donor conjugation), combination therapy (with gemcitabine or cisplatin), and nanomaterial-based delivery (e.g., liposomes and exosome-mimicking nanoparticles) have been developed to enhance efficacy, reduce toxicity, and improve bioavailability. CuB shows broad-spectrum anticancer activity, but further research is needed to clarify the mechanisms underlying its cell-specific sensitivity and interactions with the immune system. This review systematically summarizes the physicochemical properties, anticancer mechanisms, and strategies for applying CuB and suggests future research directions, providing references for scientific research and clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriterpenesNeoplasmsAntineoplastic AgentsHumansAnimalsSignal TransductionApoptosis

Stichwörter der Autor:innen

cancercucurbitacin Bmechanism of actiontoxicity

Substanzen

Triterpenescucurbitacin BAntineoplastic Agents

Autor:innen und Institutionen

  • School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.

ORCID-Profile: Xiaoxv Dong, Xingbin Yin

Förderung

  • the Young Elite Scientists Sponsorship Program by the Beijing Natural Science Foundation
  • the National Natural Science Foundation of China
  • Beijing Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Yin, D., Chen, H., Lin, S., Sun, Y., Jing, X., Chang, R., Feng, Y., Dong, X., Qu, C., Ni, J., & Yin, X. (2025). Recent Advances in the Application of Cucurbitacin B as an Anticancer Agent. International Journal of Molecular Sciences, 26(16), 8003. https://doi.org/10.3390/ijms26168003

Vancouver

Yin D, Chen H, Lin S, Sun Y, Jing X, Chang R, et al. Recent Advances in the Application of Cucurbitacin B as an Anticancer Agent. International Journal of Molecular Sciences. 2025;26(16):8003. doi:10.3390/ijms26168003

BibTeX
@article{Yin2025,
  author = {Yin, Dongge and Chen, Hongyue and Lin, Shuting and Sun, Yufei and Jing, Xiaohong and Chang, Rongrong and Feng, Yang and Dong, Xiaoxv and Qu, Changhai and Ni, Jian and Yin, Xingbin},
  title = {Recent Advances in the Application of Cucurbitacin B as an Anticancer Agent},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {16},
  pages = {8003},
  doi = {10.3390/ijms26168003}
}
Kostenlos starten →